PharmaCyte Biotech Inc. (PMCB): Price and Financial Metrics
PMCB Price/Volume Stats
| Current price | $1.02 | 52-week high | $2.42 |
| Prev. close | $1.12 | 52-week low | $1.00 |
| Day low | $1.00 | Volume | 16,494 |
| Day high | $1.12 | Avg. volume | 15,737 |
| 50-day MA | $1.15 | Dividend yield | N/A |
| 200-day MA | $1.56 | Market Cap | 7.00M |
PMCB Stock Price Chart Interactive Chart >
PharmaCyte Biotech Inc. (PMCB) Company Bio
PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PMCB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PMCB Price Returns
| 1-mo | -6.85% |
| 3-mo | -42.70% |
| 6-mo | -37.80% |
| 1-year | -49.50% |
| 3-year | -51.89% |
| 5-year | -96.24% |
| YTD | -35.03% |
| 2024 | -27.31% |
| 2023 | -26.28% |
| 2022 | 17.20% |
| 2021 | -75.12% |
| 2020 | -83.46% |